Science
Swiss Study to Prospectively Assess Value of Multi-Omic, Functional Tumor Profiling – Precision Oncology News
The TuPro study will evaluate whether a comprehensive suite of routine and emerging tests can add value to treatment decision making and improve outcomes.
This article has been updated with the number of patients involved in the study and timeline details.
NEW YORK A group of researchers in Switzerland has set out to show the feasibility of incorporating a comprehensive suite of tumor profiling technologies into the treatment decision-making process for cancer patients and prove that such a multi-omics approach will add value over standard approaches and improve precision therapy decisions.
The researchers outlined the design and aims of the Tumor…
-
Noosa News20 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News19 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General23 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News22 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops